Charming Medical Limited Class A (MCTA) Income Statement
MCTA FY2026 at a glance
Fiscal year ended March 31, 2026 · U.S. dollarsMCTA revenue and net income
Where MCTA's revenue goes
FY2026Each bar shows an amount and its share of revenue. MCTA kept −0.5% of revenue as net income.
MCTA profit margins
MCTA growth rates
to FY2026| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | −22.7% | +10.8% | — | — |
| Gross profit | −28.0% | +26.3% | — | — |
| Operating income | −90.7% | — | — | — |
| Net income | −101.9% | — | — | — |
| EPS (diluted) | −100.0% | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
MCTA income statement
| FY2026 | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|
| Revenue | $4.8M | $6.2M | $6.0M | $3.5M |
| Cost of revenue | $1.8M | $2.0M | $2.1M | $2.0M |
| Gross profit | $3.0M | $4.2M | $3.9M | $1.5M |
| Sales, general & admin | $2.7M | $2.3M | $2.3M | $1.7M |
| Total operating expenses | $4.7M | $2.8M | $2.9M | $2.0M |
| Operating income | $128,873 | $1.4M | $1.0M | −$521,336 |
| Interest income | $72,651 | $64,136 | $19,513 | $10,288 |
| Interest expense | $15,799 | $20,874 | $26,051 | $20,259 |
| Income before taxes | $133,466 | $1.4M | $1.0M | −$420,468 |
| Income taxes | — | $236,082 | $181,751 | −$84,863 |
| Net income | −$22,648 | $1.2M | $777,811 | −$305,117 |
| EBITDA | $365,339 | $1.7M | $1.4M | −$189,131 |
| EPS (diluted) | $0.00 | $0.07 | $0.05 | — |
| Gross margin | 62.6% | 67.2% | 65.1% | 42.3% |
| Operating margin | 2.7% | 22.3% | 16.8% | −14.8% |
| Net margin | −0.5% | 19.3% | 12.9% | −8.6% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in MCTA's financial statements (latest annual report filed —); data from EODHD. Sales, general & administrative expenses include sales and marketing.
MCTA financial results
In fiscal year 2026 (ended March 31, 2026), Charming Medical reported revenue of $4.8 million, down 22.7% from the year before. It had a net loss of $0.0 million, a net profit margin of −0.5%. Diluted earnings per share came to $0.00.
See the MCTA stock overview for the latest quote and news, or the MCTA chart for price history and technical indicators.
MCTA income statement FAQ
What is Charming Medical's annual revenue?
Charming Medical reported total revenue of $4.8 million for fiscal year 2026, which ended on March 31, 2026. That was down 22.7% from $6.2 million the previous year.
Is Charming Medical profitable?
No. Charming Medical reported a net loss of $0.0 million in fiscal 2026, a net profit margin of −0.5%; its operating margin was 2.7%.
What is Charming Medical's gross margin?
Charming Medical's gross margin was 62.6% in fiscal 2026: for every $100 of revenue, Charming Medical kept $63 after the direct cost of its products and services.
What are Charming Medical's earnings per share?
Charming Medical earned $-0.00 per diluted share in fiscal 2026, compared with $0.07 a year earlier.
When does Charming Medical's fiscal year end?
Charming Medical's fiscal year ends in March. The latest annual report covers the year ended March 31, 2026.